Sahar AHMED, Basem AHMED, Ghada MAHMOUD, Emam RAHIM ABDEL, Waleed NEMR

Comparative study between formalin-killed vaccine and developed gammairradiation vaccine against Mannheimia haemolytica in rabbits

Mannheimia haemolytica is responsible for considerable economic losses to sheep, goats, and cattle and other livestock industries in Egypt. This study aimed to evaluate the effectiveness of a newly developed gamma irradiation vaccine against Mannheimia haemolytica in comparison to a formalin-killed vaccine. Three groups of rabbits were used in this study. Group 1 animals were inoculated with 4 × 109 bacterial cells per dose of the formalin-killed vaccine. Group 2 was inoculated with 2 × 109 bacterial cells per dose of gamma-irradiated vaccine. Group 3 (control group) was injected with 2 mL of sterile PBS. The vaccines were injected subcutaneously into experimental animals twice with 3-week intervals between inoculations. Three weeks after the second vaccination dose, the animals in all groups were infected with M. haemolytica twice with 1-week intervals between inoculations. Blood samples were collected weekly after the first vaccination until one week after the second M. haemolytica infection challenge. ELISA results revealed that the gamma irradiation vaccine developed in this study provided protective effects that reached high levels at the time of challenge. Furthermore, the second dose of gamma irradiation vaccine could act as a booster dose resulting in increased antibody production

PDF

___

1. Meeusen EN, Walker J, Peters A, Pastoret P, Jungersen G. Current status of veterinary vaccines. Clin Microbiol Rev 2007; 20: 489510.
2. Curtiss R. Bacterial infectious disease control by vaccine development. J Clin Invest 2002; 110: 10611066.
3. Plotkin S. Vaccines, vaccination, and vaccinology. J Infect Dis 2003; 187: 13471359.
4. Plotkin S. Correlates of vaccine-induced immunity. Clin Infect Dis 2008; 47: 401409.
5. Eberl M, Langerman J, Frost P, Vervenne R, Van dam G, Deelder A, Thomas A, Coulson P, Wilson R. Cellular and humoral immune responses and protection against schistosomes induced by a radiation-attenuated vaccine in chimpanzees. Infect Immun 2001; 69: 53525362.
6. Datta S, Okamoto S, Hayashi T, Shin S, Mihajlov I, Fermin A, Guiney D, Fierer J, Raz E. Vaccination with irradiated Listeriainduces protective T cell immunity. Immunity 2006; 25: 143152.
7. Zorgi NE, Costa A, Galisteo AJ, Nanci N, de Andrade HF. Humoral responses and immune protection in mice immunized with irradiated T. gondii tachyzoites and challenged with three genetically distinct strains of T. gondii. Immunol Lett 2011; 138: 187196.
8. MacFaddin JF. Biochemical Tests for Identification of Medical Bacteria. 3rd ed. Philadelphia, PA, USA: Lippincott Williams and Wilkins; 2000.
9. James G. Universal bacterial identification by PCR and DNA sequencing of 16S rRNA gene. In: Schuller M, Sloots TP, James GS, Halliday CL, Carter IWJ, editors. PCR for Clinical Microbiology. Amsterdam, the Netherlands: Springer; 2010. pp. 209214.
10. Selim SA, Ghoneim ME, Mohamed KF. Vaccinal efficacy of genetically inactivated phospholipase D against caseous lymphadenitis in small ruminants. International Journal of Microbiological Research 2010; 1: 129136.
11. Ruzauskas M. Development and assay of inactivated Pasteurellavaccine for rabbits. Biologija 2005; 2: 3539.
12. Aquino S, Ferreira F, Ribeiro DHB, Corrêa B, Greiner R, Villavicencio ALCH. Evaluation of viability of Aspergillus flavus and aflatoxins degradation in irradiated samples of maize. Braz J Microbiol 2005; 36: 352356.
13. Abo-State M, Hammad A, Swelim M, Gannam R. Enhanced production of cellulase (S) by Aspergillus spp. isolated from agriculture wastes by solid state fermentation. American-Eurasian Journal of Agriculture & Environmental Science 2010; 8: 402410.
14. Lu YS, Pakes SP. Protection of rabbits against experimental pasteurellosis by a streptomycin-dependent Pasteurella multocida serotype 3: a live mutant vaccine. Infect Immun 1981; 34: 10181024.
15. Pipkin B. Medical Statistics Made Easy. 5th ed. New York, NY, USA: Churchill Livingstone; 1984.
16. Sabri MY, Shahrom-Salisi M, Emikpe BO. Comparison prior and post vaccination of inactivated recombinant vaccine against mannheimiosis in Boer goats farm in Sabah. Journal of Vaccines & Vaccination 2013; 4: 173.
17. Kaoud H, El-Dahshan A, Zaki M, Shimaa A. Occurrence of Mannheimia haemolytica and Pasteurella trehalosi among ruminants in Egypt. New York Science Journal 2010; 3: 135141.
18. Confer AW, Ayalew S, Montelongo M, Step DL, Wray JH, Hansen RD, Panciera RJ. Immunity of cattle following vaccination with a Mannheimia haemolytica chimeric PlpELKT (SAC89) protein. Vaccine 2009; 27: 17711776.
19. Sun T. Evaluation of a vaccine against Mannheimia haemolyticaand Pasteurellamultocida in sheep. Honors Thesis, Cornell University, Ithaca, NY, USA, 2009.
20. Syaifudin M, Tetriana D, Darlina D, Nurhayati S. The feasibility of gamma irradiation for developing malaria vaccine. Atom Indonesia 2011; 37: 91101.
21. Dabral N, Moreno-Lafont M, Sriranganathan N, Vemulapalli R. Oral immunization of mice with gamma-irradiated Brucella neotomae induces protection against intraperitoneal and intranasal challenge with virulent B. abortus 2308. PLoS One 2014; 9: 112.
22. Petre J, Pizza M, Nencioni ML, Podda A, De Magistris MT, Rappuoli R. The reaction of bacterial toxins with formaldehyde and its use for antigen stabilization. Dev Biol Stand 1996; 87: 125134.